Hint 1: The centralised simultaneous global co-ordination is back …https://x.com/FurkanGozukara/status/2053416859223896296?s=20
Hint 2: might there be the same motivation …?https://x.com/ShadowofEzra/status/2053240365436592189?s=20
Hint 3 : Simultaneous breakouts across the globe: Key Details of the noting a 12 day to 27 day incubation period.
Outbreak Origin: The ship departed Ushuaia, Argentina, on April
1, 2026. It traveled through the South Atlantic, with stops including Antarctica, South Georgia Island, Tristan da Cunha, Saint Helena, and Ascension Island. Exposure is believed to have occurred via rodents (likely Andes virus/ANDV, endemic in parts of South America like Argentina/Chile), with possible limited person-to-person transmission (a feature unique to Andes virus among hantaviruses).
Total cases: 8 (6 confirmed as Andes virus via PCR/sequencing + 2 suspected/probable), including 3 deaths (case fatality ratio ~38%). Cases include passengers and crew from multiple nationalities.
Locations of cases or monitoring:On/near the ship: Cases initially reported aboard or evacuated from the vessel (off Cabo Verde/Cape Verde area). Some patients were treated or died there.
South Africa: At least one critically ill patient evacuated to Johannesburg ICU.
Europe: Confirmed/suspected cases linked to passengers/crew returning to the Netherlands (including Dutch nationals/crew), Switzerland (Zurich), UK (British nationals; one suspected on Tristan da Cunha), and others (e.g., Germany).
Other countries: Passengers from ~23 nationalities total; cases or contacts traced to additional countries. The ship later headed toward Spain
Hint 4: The Andes variety of Hantavirus does spread human to human, but this does not explain the sumulataneous breakouts inside the incubation period. The tranmission noted in research article 3. below explains how it actually spreads, and its rate of spread. Close physical contact with symptomatic patient, usually in the same household/family.
Previous research on Andes Hantavirus.
1.What: Kuenzli, A.B., Marschall, J., Schefold, J.C., Schafer, M., Engler, O.B., Ackermann-Gäumann, R., Reineke, D.C., Suter-Riniker, F. and Staehelin, C., 2018. Hantavirus cardiopulmonary syndrome due to imported Andes hantavirus infection in Switzerland: a multidisciplinary challenge, two cases and a literature review. Clinical Infectious Diseases, 67(11), pp.1788-1795.
-
Where: Polop, F.J., Provensal, M.C., Pini, N., Levis, S.C., Priotto, J.W., Enría, D., Calderón, G.E., Costa, F. and Polop, J.J., 2010. Temporal and spatial host abundance and prevalence of Andes Hantavirus in Southern Argentina. EcoHealth, 7(2), pp.176-184.
-
Where: Astorga, F., Escobar, L.E., Poo-Muñoz, D., Escobar-Dodero, J., Rojas-Hucks, S., Alvarado-Rybak, M., Duclos, M., Romero-Alvarez, D., Molina-Burgos, B.E., Peñafiel-Ricaurte, A. and Toro, F., 2018. Distributional ecology of Andes hantavirus: a macroecological approach. International Journal of Health Geographics, 17(1), p.22.
-
How: Padula, P., Figueroa, R., Navarrete, M., Pizarro, E., Cadiz, R., Bellomo, C., Jofre, C., Zaror, L., Rodriguez, E. and Murua, R., 2004. Transmission study of Andes hantavirus infection in wild sigmodontine rodents. Journal of Virology, 78(21), pp.11972-11979.
-
How: Martinez-Valdebenito, C., Calvo, M., Vial, C., Mansilla, R., Marco, C., Palma, R.E., Vial, P.A., Valdivieso, F., Mertz, G. and Ferrés, M., 2014. Person-to-person household and nosocomial transmission of andes hantavirus, Southern Chile, 2011. Emerging infectious diseases, 20(10), p.1629.
Hint 5: There are well researched preventive methods and treatments in place already
Two recombinant human monoclonal antibodies that protect against lethal Andes hantavirus infection in vivo
https://www.science.org/doi/pdf/10.1126/scitranslmed.aat6420
Specific and versatile monoclonal antibodies for hantavirus research
https://journals.asm.org/doi/full/10.1128/msphere.00612-25
Its all about funds and control…like the last time and the world knows this now.Redirecting...
